Business Context and Reporting Period
This Form 6-K filing by Tower Semiconductor Ltd. (TowerJazz) is dated June 3, 2013. The filing announces the terms of a proposed rights offering to eligible security holders, including shareholders, warrant holders, capital note holders, and option holders. The record date for the offering is June 13, 2013.
Key Financial Metrics and Capital Structure
The filing focuses on capital raising rather than operational financial results. Key metrics regarding the proposed offering include:
- Expected Gross Proceeds: Approximately $60 million if all rights and Series 8 warrants are exercised. An additional $45 million is expected if all Series 9 warrants are exercised.
- Proceeds Breakdown: 40% of the initial $60 million is expected from the initial rights exercise, with the balance from Series 8 warrant exercises.
- Major Shareholder Commitment: Israel Corporation Ltd. has committed to invest approximately $17 million by exercising all rights and underlying Series 8 warrants.
- Subscription Terms: One right is issued for every 44 ordinary shares. Each right allows the purchase of four ordinary shares, six Series 8 warrants, and five Series 9 warrants for an initial consideration of $20 per right.
The filing text does not provide current revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes and Offering Structure
The primary material change is the announcement of the specific terms for the equity rights distribution. Key structural details include:
- Ex-Date: June 13, 2013 (the last trading day to receive rights is June 12, 2013).
- Exercise Period: Rights are exercisable from June 13, 2013, to June 27, 2013.
- Warrant Terms: Series 8 warrants are short-term (exercisable June 30 to July 22, 2013). Series 9 warrants are exercisable until June 27, 2017, at a price of $7.33 per share.
- Trading Venues: Rights and warrants will trade on the Tel Aviv Stock Exchange (TASE) but not on any US stock exchange.
Guidance, Outlook, and Risks
Management commentary highlights the commitment of Israel Corporation Ltd. as an expression of belief in the Company. The filing includes a Safe Harbor statement regarding forward-looking statements, noting that actual results may vary due to risks and uncertainties. Specific risk factors are referenced in the Company's most recent Forms 20-F, F-3, 10-K, and 10-Q filings. No specific operational guidance or outlook for revenue or earnings is provided in this document.
Important Facts for Investor Verification
- Verify the final prospectus supplements filed with the SEC and Israel Securities Authority for complete offering details.
- Confirm the actual exercise rate of the rights and warrants to determine if the projected $60 million to $105 million in proceeds will be realized.
- Review the dilution impact on existing shareholders given the issuance of approximately 1.2 million rights and associated warrants.
- Check the trading status of the rights on the TASE on June 24, 2013, for holders wishing to sell rather than exercise.